Literature DB >> 21442184

Venous thromboembolism after major orthopaedic surgery: a population-based cohort study.

Davide Imberti1, Cosetta Bianchi, Antonella Zambon, Andrea Parodi, Luca Merlino, Massimo Gallerani, Giovanni Corrao.   

Abstract

Venous thromboembolism (VTE) is an important cause of morbidity and mortality following major orthopaedic surgery. However, the incidence of VTE and the role of additional risk factors have not yet been well explored in Italian clinical practice. The objective of the study is to estimate the incidence of VTE in the 3 months following elective hip and knee replacement (HR, KR) in a large cohort of patients, and the association between some selected risk factors and the occurrence of VTE. A large cohort study based on the record linkage between automated archives of the National Health System was analysed. In particular, all the residents in the Lombardy Region (Italy) who underwent HR and KR between 2005 and 2008 were followed for 3 months after surgery. The odds ratio (OR) of VTE associated with selected known risk factors was estimated by multivariate logistic regression. Amongst the 69,770 patients included in the study, 2,393 experienced at least one VTE event during the follow-up; the overall risk of VTE after HR or KR was 3.4%. The adjusted odds of experiencing a VTE event was higher in male patients (OR 1.11; 95% confidence interval 1.01-1.21), aged 60 years or older (1.30; 1.00-1.68), undergoing KR (1.47; 1.35-1.61), with previous deep vein thrombosis (1.96; 1.20-3.19), pulmonary embolism (3.25; 1.84-5.75) or cancer (1.21; 1.00-1.46). In conclusion, the incidence of VTE after elective HR and KR in the Italian clinical practice is high. Our results suggest the need of optimising the management of thromboprophylaxis to further reduce postoperative VTE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442184     DOI: 10.1007/s11739-011-0567-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  28 in total

1.  The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial.

Authors:  Neree Claes; Frank Buntinx; Johan Vijgen; Jef Arnout; Jos Vermylen; Steffen Fieuws; Herman Van Loon
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

Review 2.  Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Authors:  R D Hull; G F Pineo; P D Stein; A F Mah; S M MacIsaac; O E Dahl; M Butcher; R F Brant; W A Ghali; D Bergqvist; G E Raskob
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

3.  Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism.

Authors:  D A Ganz; R J Glynn; H Mogun; E L Knight; R L Bohn; J Avorn
Journal:  J Gen Intern Med       Date:  2000-11       Impact factor: 5.128

4.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

Review 5.  Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.

Authors:  Raymond Verhaeghe
Journal:  Acta Orthop Belg       Date:  2005-06       Impact factor: 0.500

6.  Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).

Authors:  Nazim Isma; Peter J Svensson; Anders Gottsäter; Bengt Lindblad
Journal:  Thromb Res       Date:  2009-06-03       Impact factor: 3.944

7.  Heparin versus danaproid for prevention of venous thromboembolism after hip surgery.

Authors:  J Nakase; Y Toribatake; Y Mouri; H Seki; K Kitaoka; K Tomita
Journal:  J Orthop Surg (Hong Kong)       Date:  2009-04       Impact factor: 1.118

8.  Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.

Authors:  G Corrao; A Zambon; V Conti; F Nicotra; C La Vecchia; C Fornari; G Cesana; P Contiero; G Tagliabue; R E Nappi; L Merlino
Journal:  Ann Oncol       Date:  2007-09-04       Impact factor: 32.976

9.  Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.

Authors:  Andrew F Shorr; Louis M Kwong; Matthew Sarnes; Laura Happe; Eileen Farrelly; Nikita Mody-Patel
Journal:  Thromb Res       Date:  2007-04-20       Impact factor: 3.944

10.  Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery.

Authors:  F Randelli; F Biggi; G Della Rocca; P Grossi; D Imberti; R Landolfi; G Palareti; D Prisco
Journal:  J Orthop Traumatol       Date:  2011-03
View more
  5 in total

Review 1.  Postoperative risk of venous thromboembolism in rheumatic disease patients.

Authors:  Lauren E Wong; Anne R Bass
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

2.  Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.

Authors:  Tzu-Fei Wang; Paul E Milligan; Catherine A Wong; Eli N Deal; Mark S Thoelke; Brian F Gage
Journal:  Thromb Haemost       Date:  2013-10-17       Impact factor: 5.249

3.  Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.

Authors:  Chiara Piovella; Fabio Dalla Valle; Javier Trujillo-Santos; Raffaele Pesavento; Leonor López; Llorenç Font; Reina Valle; Dolores Nauffal; Manuel Monreal; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2014-05-17       Impact factor: 3.397

Review 4.  Comparison of the Efficacy and Safety of Rivaroxaban and Enoxaparin as Thromboprophylaxis Agents for Orthopedic Surgery-Systematic Review and Meta-Analysis.

Authors:  Ikhwan Rinaldi; Ihya Fakhrurizal Amin; Yuli Maulidiya Shufiyani; Idham Rafly Dewantara; Brenda Cristie Edina; Kevin Winston; Yusuf Aji Samudera Nurrobi
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

5.  The Hypercoagulable Profile of Patients with Bone Tumors: A Pilot Observational Study Using Rotational Thromboelastometry.

Authors:  Andreas G Tsantes; Ilectra Loukopoulou; Dimitrios V Papadopoulos; Ioannis G Trikoupis; Anastasios G Roustemis; Stavros Goumenos; Rozeta Sokou; Konstantina A Tsante; Anastasios G Kriebardis; Panagiotis Koulouvaris; Dimitra Houhoula; Daniele Piovani; Panayiotis J Papagelopoulos; Stefanos Bonovas; Argirios E Tsantes
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.